[
    [
        {
            "time": "2023-10-18",
            "original_text": "Pharma Companies Are Rushing to Treat a Little-Known Liver Disease. Investors Should Be Skeptical.",
            "features": {
                "keywords": [
                    "Pharma",
                    "Companies",
                    "Rushing",
                    "Treat",
                    "Little-Known",
                    "Liver Disease",
                    "Investors",
                    "Skeptical"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Pharma Companies Are Rushing to Treat a Little-Known Liver Disease. Investors Should Be Skeptical.",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]